Conavi Medical Corp. CNVI.V

Company Overview

Conavi Medical Corp. is a Canadian medical technology company focused on cardiovascular imaging solutions used in interventional cardiology procedures. The company develops and commercializes hybrid intravascular imaging systems that combine intravascular ultrasound (IVUS) and optical coherence tomography (OCT) technologies into a single platform to support the diagnosis and treatment of coronary artery disease. Conavi operates within the broader medical device, cardiovascular imaging, and interventional healthcare technology industries.

The company’s primary commercial platform is the Novasight Hybrid System, which is designed to provide physicians with detailed imaging of coronary arteries during minimally invasive procedures. Revenue generation has historically been tied to system placements, imaging catheters, and related procedural products and collaborations. Conavi’s strategic positioning is centered on offering dual-modality imaging capabilities in a market where many competitors provide only a single imaging technology. The company traces its origins to research and technology development in Canada focused on advanced intravascular imaging and has evolved into a publicly traded cardiovascular device developer listed on the TSX Venture Exchange under the symbol CNVI.